Evidence map›Paper›PMID 8634613›Full record

SynthesisBMJ (Clinical research ed.)1996

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

D Marshall, O Johnell, H Wedel

Registry-linked trialOpen access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in BMJ (Clinical research ed.), 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00145977 (Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis), which is not on this map. Cited by 1,109 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,109citing papers in PubMed, 13 pooled it
67.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00145977 nacompletednot on this mapstarted 2001, after this paper: background citation

Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis

TypeinterventionalSponsorUniversity of ChicagoRan2001 to 2009Enrolled36ConditionsOsteoporosis, OsteopeniaArmsAlendronate, Calcium Citrate, Vitamin D
3 · Its place in the literature

Who cites it

1,109 citing papers in PubMed, 13 syntheses or guidelines pooled it, 3,693 citations in OpenAlex.

  1. Pooled it
  2. Forearm BMD predicts fracture independently of FRAX.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  3. Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  4. A meta-analysis of smoking and fracture risk to update the FRAX® tool.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  5. Pooled it
  6. Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  7. Guideline
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Clinical effectiveness of reduction and fusion versus in situ fusion in the management of degenerative lumbar spondylolisthesis: a systematic review and meta-analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Pooled it
  12. Pooled it
  13. Pooled it
  14. Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Trial
  15. A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

1,049 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

D MarshallSwedish Council on Technology Assessment in Health Care, Stockholm, Sweden.
O Johnell
H Wedel
Malmö University · SENordic School of Public Health · SESwedish Council on Technology Assessment in Health Care · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the ability of measurements of bone density in women to predict later fractures.

designMeta-analysis of prospective cohort studies published between 1985 and end of 1994 with a baseline measurement of bone density in women and subsequent follow up for fractures. For comparative purposes, we also reviewed case control studies of hip fractures published between 1990 and 1994. SUBJECTS: Eleven separate study populations with about 90,000 person years of observation time and over 2000 fractures.

main outcome measuresRelative risk of fracture for a decrease in bone mineral density of one standard deviation below age adjusted mean.

resultsAll measuring sites had similar predictive abilities (relative risk 1.5 (95% confidence interval 1.4 to 1.6)) for decrease in bone mineral density except for measurement at spine for predicting vertebral fractures (relative risk 2.3 (1.9 to 2.8)) and measurement at hip for hip fractures (2.6 (2.0 to 3.5)). These results are in accordance with results of case-control studies. Predictive ability of decrease in bone mass was roughly similar to (or, for hip or spine measurements, better than) that of a 1 SD increase in blood pressure for stroke and better than a 1 SD increase in serum cholesterol concentration for cardiovascular disease.

conclusionsMeasurements of bone mineral density can predict fracture risk but cannot identify individuals who will have a fracture. We do not recommend a programme of screening menopausal women for osteoporosis by measuring bone density.

Indexed as

Bone DensityAgedCohort StudiesFemaleFollow-Up StudiesForecastingFractures, BoneHip FracturesHumansOsteoporosis, PostmenopausalPredictive Value of TestsProspective StudiesRisk FactorsSensitivity and Specificity

Identifiers

PMID8634613
PMCPMC2351094
OpenAlexW2036125852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.